Circulating human CD4 + CD25 ++ CD127 2 FOXP3 + T cells with a persistent demethylated regulatory T cell (Treg)-specific demethylated region Foxp3 gene are considered natural Tregs (nTregs). We have shown that it is possible to identify functional Agreactive nTregs cells for a range of different common viral and vaccination Ags. The frequency of these Ag-reactive nTregs within the nTreg population is strikingly similar to the frequency of Ag-reactive T effector cells within the CD4 + T cell population. The Ag-reactive nTregs could be recognized with great specificity by induction of CD154 expression. These CD154 + Ag-reactive nTregs showed a memory phenotype and shared all phenotypical and functional characteristics of nTregs. The isolated CD154 + nTregs could be most efficiently expanded by specific antigenic stimulation, while their Ag-reactive suppressive activity was maintained.
R egulatory CD4
+ T cells (Tregs) are considered to be crucial for the suppression of excessive T cell responses that may cause damage to the organism. FOXP3 is a key molecule for identification of suppressive function of Tregs. Deficiency or dysfunction of FOXP3 + Tregs in humans and Foxp3 Tregs in rodents is associated with T cell-mediated autoimmune diseases, allergies, and inflammatory bowel disease. Additionally, Tregs may be important in establishing tolerance to organ transplants (1) .
The ontogeny of Tregs may involve several differentiation pathways, with thymus-derived and induced Tregs (iTregs) being the main ones. Tregs generated within the thymus are called natural Tregs (nTregs) (2) . Additionally, at least in vitro Tregs may be induced from a FOXP3
2 T cell population using the appropriate cytokine milieu, including TGF-b. These iTregs are phenotypically indistinguishable from nTregs, are FOXP3 + , and can be generated as Ag-reactive T cells as opposed to nTregs (4) . Recently, demethylation at a highly conserved region within the FOXP3 gene (Treg-specific demethylated region [TSDR] ) was found to discriminate between natural Tregs (highly demethylated TSDR) and induced Tregs (highly methylated TSDR) (5, 6) .
Within the peripheral blood of healthy humans a relative stable population of Tregs can be recognized that comprise ∼5-10% of the total CD4 + T cell population. These FOXP3 + cells express high levels of CD25 and low levels of CD127 (FOXP3 + CD25 ++ CD127 2 CD4 + T cells) (7) . Recently, it has been shown that this cell population is composed of Tregs with a naive and memory T cell phenotype based on differential expression of the CD45 isoforms CD45RO (memory phenotype) and CD45RA (naive phenotype) (8, 9) . The memory Tregs behave similar to memory cells of effector CD4 + T cells (Teff), as they have short telomeres and a remarkably high turnover rate (10) . Sequence-based T cell clonotype tracing of human peripheral blood and transfer of CD45RA + Tregs into NOD/SCID/common g-chain-deficient mice showed conversion of these CD45RA + Tregs into CD45RA 
Foxp3
+ cells (8) . An unresolved issue that remains is whether Ag-reactive Tregs are present within the human nTreg population, as such cells cannot be directly identified. Previous studies have indicated the existence of HIV and CMV Ag-reactive Tregs in the peripheral blood but failed to show their existence on the single cell level. It has been postulated that these Ag-reactive Tregs may originate from activated CD4 + Teff and are in fact iTregs (7) . Alternatively, Ag-reactive Tregs could stem from conversion of naive FOXP3 + nTregs into memory nTregs, in a similar fashion as the Ag-reactive memory CD4 + Teff develop from FOXP3 2 naive CD4 + T cells (11) . Identification on the single cell level of Ag-reactive nTregs would allow for tracking Ag-reactive responses. Isolation and propagation of such Ag-reactive nTregs could be highly useful for immunotherapy, as this would avoid any unwanted generalized suppression of immune responses (12) . Previously, we have used membrane-bound CD154 (CD40L) expression in a live cell assay to detect and isolate human Ag-reactive CD4 + Teff with high sensitivity and specificity (13, 14) . In this study we followed this strategy to show the presence and characteristics of Ag-reactive nTregs.
surface Ag (HBs Ag) with weekly isolation of PBMCs thereafter, using the protocols published previously (15, 16) . All individuals included gave informed consent, and the local Medical Ethical Committee approved the study. It was conducted according to the principles of the Declaration of Helsinki and in compliance with International Conference on Harmonization/ Good Clinical Practice regulations.
Cell sorting experiments
PBMCs were enriched for T lymphocytes using the Pan T cell isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Enriched T lymphocytes were prepared for sorting experiments using the following mAbs: AmCyanlabeled CD3 (BD Pharmingen, Erembodegem, Belgium), Pacific Bluelabeled CD4 (BD Pharmingen), PeCy7-labeled CD25 (epitope A; BD Pharmingen), PE-labeled CD127 (BD Pharmingen), and inclusion of a live/ dead marker ViaProbe (7- 2 ) T cells (17) , using allophycocyaninlabeled CD45RO (BD Pharmingen) and FITC-labeled CCR7 (R&D Systems Europe, Abingdon, U.K.).
Methylation analysis for TSDR FOXP3
Genomic DNA from total PBMCs and FACS-sorted fractions was isolated using the QIAamp DNA Micro kit (Qiagen Benelux, Venlo, The Netherlands) following the protocol for small volumes of blood. Bisulfite treatment using the EZ DNA Methylation-Direct kit (Zymo Research from BaseClear, Leiden, The Netherlands) according to the manufacturer's instructions converted unmethylated cytosines into uracil, whereas methylated cytosines remained unchanged. The TSDR of FOXP3 was amplified by quantitative PCR using the StepOnePlus real-time PCR system (Applied Biosystems Europe, Nieuwerkerk aan den IJssel, The Netherlands) with methylation-and demethylation-specific primers and probes (6) . The percentage of TSDR demethylation was calculated as the ratio of unmethylated DNA copy numbers and the sum of methylated and unmethylated DNA copy numbers. 5 ) either loaded with CMV Ag (34 mg/ml; Microbix Biosystems, Toronto, ON, Canada) or not (background). Stimulation was done in the presence of costimulation, that is, Abs directed against CD28 (1 mg/ml; Serotec/Morphosys, Duesseldorf, Germany) and CD49d (1 mg/ml; BD Pharmingen). Anti-CD40 (1 mg/ml, clone 14G7; Sanquin, Amsterdam, The Netherlands) was added when CD154 was stained on the cell surface. The autologous PBMCs that were used as APCs were labeled with 5 mM CFSE (Molecular Probes Europe, Leiden, The Netherlands) for 10 min at 37˚C. At the different time points, cells were harvested and stained to determine percentages of CD154-and CD137-expressing cells, respectively. Percentages of CD154 or CD137, induced by CMV Ag-loaded autologous CFSE-labeled PBMCs, were corrected for the background (i.e., autologous CFSE-labeled PBMCs not loaded with Ags) (14) . + Teff in individuals that were tested seropositive for CMV Ag (34 mg/ ml), varicella-zoster virus (VZV) Ag (30 mg/ml; Microbix Systems), or were previously immunized against hepatitis B virus (5 mg/ml HBs Ag; Bioconnect, Huissen, The Netherlands) or tetanus toxoid (37.5 Lf/ml; Dutch National Institute for Public Health and the Environment, Bilthoven, The Netherlands). Similar as described above, the percentages of Ag-reactive CD154-expressing Tregs and CD4 + Teff were corrected for the background signal.
Kinetics

Expansion of sorted fractions
Tregs or the CD154-enriched and CD154-depleted Tregs (at 1 3 10 4 /well for polyclonal expansion and 2.5 3 10 4 /well for Ag-reactive expansion) were expanded for 7-10 d using either CD3/CD28 T cell expander dynabeads (Invitrogen Dynal, Oslo, Norway) at a 1:1 ratio or CMV Agloaded (34 mg/ml) irradiated (30 Gy) autologous PBMCs (1 3 10 5 /well). Expansion was performed in standard culture medium supplemented with 25 IU/ml recombinant human IL-2 (Alloga, Veghel, The Netherlands) and 10 ng/ml recombinant human IL-15 (PeproTech, Rocky Hill, NJ). Every 3 d, fresh culture medium supplemented with cytokines was added to the wells.
Suppression assay
Suppressive capacity was tested using the freshly isolated, the Ag-reactive, and/or the polyclonal expanded Treg fractions (unseparated or CD154-enriched and CD154-depleted). Briefly, Tregs were transferred in triplicate to the wells and used at different ratios (i.e., 1:5 to 1:2560). Subsequently, 5 3 10 4 CD3 + Teff (responder cells) were added in triplicate to the wells. Irradiated (40 Gy) autologous PBMCs either loaded with the different Ags-that is, CMV Ag (34 mg/ml), VZV Ag (30 mg/ml), HBs Ag (5 mg/ml), Tet-Tox (37.5 Lf/ml), and PHA (1 mg/ml; Roche Diagnostics, Mannheim, Germany)-or not were used as stimulators and used at a concentration of 5 3 10 4 /well. At day 5, [ 3 H]thymidine was added and following 16-18 h incorporation, the plates were harvested, and radioactivity was counted using a liquid scintillation counter. The cpm or proliferation in presence of Tregs was related to proliferation in the absence of Tregs and depicted as percentages.
Cytokine-producing capacity
Percentages of cytokine-producing cells were determined by stimulating both Tregs and CD4 + Teff either in the presence of costimulation only (anti-CD28 and anti-CD49d both at 1 mg/ml) or with the combination of PMA (50 ng/ml; Sigma-Aldrich, St. Louis, MO) and ionomycin (1 mg/ml; Sigma-Aldrich) for 24 h, of which the last 12 h were in the presence of GolgiPlug (BD Biosciences). Subsequently, the cells were harvested and the cell surface was stained using Abs directed against CD3, CD4, and a viability marker (7-AAD). Following fixation and permeabilization, intracellular staining was performed using mAbs directed against FOXP3 (Bender MedSystems), IL-2, IFN-g, or TNF-a (the last three from BD Pharmingen) (18, 19) . Percentages of cytokine-producing cells within the Tregs were performed in the context of FOXP3 expression.
Statistical analyses
For comparisons between groups, the t test, Mann-Whitney U test, oneway ANOVA, or Kruskal-Wallis test was used, as appropriate. Post hoc analysis was performed using the Bonferroni test for multiple comparisons or the Mann-Whitney U test. A p value of ,0.05 for two sides was considered statistically significant.
Results
Ag-reactive Tregs can be detected by CD154 expression in a live cell assay Typically, Ag-reactive T cells are found at very low frequencies (1:10,000 or less of total circulating T cells) in the peripheral blood of healthy individuals. The exception to this rule is CMV Agreactive T cells that can be detected at a much higher frequency of 1:1000 to 1:100. Therefore, we started our study with CMV Ag, as this allowed for relatively easy detection and isolation of Agreactive T cells, using the CD154 live cell assay. 1G) . Moreover, the Tregs showed highly demethylated TSDR FOXP3 as compared with CD4 + Teff that contained predominantly methylated TSDR FOXP3 (Fig. 1I ). In the presence of CMV Ag, CD154 + T cells were readily and consistently detected in both T cell populations in CMV-seropositive donors (Fig. 2) . In contrast, CMV-seronegative donors did not have a CD154 signal above background (data not shown) (14) . The background was very low in both populations (,0.01%) when freshly isolated T cells were used. Kinetic analysis of Ag-reactive CD154 + T cells showed a typical difference between CD4 + Teff and Tregs ( Fig.  2A-F) . The CD4 + Teff ( Fig. 2A, 2B , 2E) showed a rapid but biphasic response (maximum at 6 and 24 h) of cell surface CD154 expression, whereas in the Tregs (Fig. 2C, 2D, 2F ) only a few CD154 + cells were observed at 6 h. However, sorting of both populations was necessary to allow for discrimination of the CD154 + CD4 + Teff and CD154 + Tregs at 24 h because the activated CD154 + CD4 + Teff increased their expression of CD25 (Fig.  2I ) and downregulated expression of CD127. This resulted in an average 30-50% overlap between both populations of Ag-reactive T cells at 24 h. It is known that activated CD4 + Teff may become FOXP3 + (20) , but at 24 h the CD154 + Tregs still showed a significant higher FOXP3 expression (Fig. 2G) . Additionally, the percentage demethylated TSDR FOXP3 remained high in CD154 + Tregs as compared with CD154 + CD4 + Teff (Fig. 2H) , even after expansion of .80% of the TSDR FOXP3 of CD154 + Tregs was demethylated (data not shown).
Membrane-bound CD137 has been used to detect Ag-reactive T cells (21) , and CD137 + cells could be detected after CMV Ag stimulation in the sorted Tregs (Fig. 2M) . However, in contrast to the CD154 live cell assay, the expression in time of CD137 + Agreactive T cells was similar for CD4 + Teff and Tregs and reached the maximum at 24 h (Fig. 2N, 2O) . We continued the experiments with the CD154 live assay, as CD137 background signals were in general higher and could vary considerably among donors.
CD154
+ Tregs have a memory phenotype and express inflammatory cytokines after polyclonal stimulation Within the CD4 + Teff population, cells can be classified in subsets based on the expression of CCR7 and CD45RO isoform on their cell membrane. This leads to a division into three major subsetsnaive T cells (CCR7   +   CD45RO 2 ), central memory T cells (CCR7 + CD45RO + ), and effector memory T cells (CCR7 2 CD45RO + )-that correlate with increasing T cell differentiation (16) . Within the Treg population a similar subset distribution was observed as for the CD4 + Teff population ( Fig. 3B and 3A , respectively). The CD154 + CD4 + Teff and CD154 + Tregs were predominantly found within the memory compartment (Fig. 3C) .
As expected, substantially lower numbers of Tregs secreting IL-2 (6.4 6 2.4%), IFN-g (1.5 6 0.6%), or TNF-a (8.7 6 2.8%) were found compared with the CD4 + Teff population (IL-2 + , 30.3 6 3.3%; IFN-g + , 9.9 6 2%; and TNF-a, 22.8 6 6.6%) after polyclonal stimulation with PMA/ionomycin (Fig. 3H-K and 3D -G, respectively). More than 98% of the cytokine-producing Tregs coexpressed FOXP3 (Fig. 3I-K) .
+ Tregs can be expanded in an Ag-specific manner and are potent suppressors Next, the CMV Ag-specific CD154 + Tregs were sorted (Fig. 4A-C) and compared with CD154-depleted Tregs for their suppressive function either immediately (Fig. 4D, 4E) or following expansion (Fig. 4I , where only results of CMV Ag-expanded CD154-expressing Tregs are displayed). The CD154 + Tregs were significantly better suppressors of CMV Ag-induced T cell proliferation compared with the CD154-depleted Tregs (Fig. 4D, 4F ), although both cell populations showed a similar efficacy in suppressing polyclonal PHA-induced T cell proliferation (Fig. 4E,  4F) . (Fig. 4G) . These results could be replicated by using VZV Ag in cultures of Tregs derived from VZV-seropositive donors, but again not in VZV-seronegative donors (data not shown). The CD154-enriched Tregs could be expanded more efficiently (yielding higher cell numbers) when compared with unseparated Tregs (Fig. 4G ) using CMV Ag. In contrast, CD154-depleted Treg cultures showed no significant expansion in response to CMV Ag, and expansion was comparable to cytokine-only conditions. Expanded CMVAg-specific CD154 + Tregs showed stable high FOXP3 expression (Fig. 4I) ; that is, .95% of these Tregs still expressed FOXP3. These CMV Ag-expanded CD154-expressing Tregs were potent suppressors of CMVAg-induced T cell proliferation (Fig. 4I) . Additionally, they showed a modest suppression of T cell proliferation to other common Ags but only at the highest ratios of Tregs/ CD3 + Teff (Fig. 4I) . These results indicate that CMV Ag-reactive CD154 + Tregs, when expanded in an Ag-specific manner, remain predominantly Ag-reactive in their suppressor function.
Proliferation in cpm is given in Supplemental Fig. 1A-D . Additionally, a kinetic analysis did not reveal a shift in the proliferative response of CD3 + Teff to CMV Ag in the presence of 1:5 CMV Agexpanded CD154 + Tregs. The strong suppression observed at day 6 was therefore unlikely to be caused by exhaustion of this culture (Supplemental Fig. 1E ).
Ratio of Ag-reactive CD154
+ Tregs to CD154
Not only CMV Ag, but a number of other common Ags such as VZV Ag, HBsAg, and Tet-Tox showed a CD154 + response in the Treg population (Fig. 5A) . Independent of the frequency of Agreactive T cells, a strikingly similar ratio for the percentage of CD154 + CD4 + Teff/percentage of CD154 + Tregs was found for the different Ags tested (Fig. 5B) . This ratio was on average 10:1, and similar to the amount of Tregs in the circulation, when tested in the unstimulated healthy individual.
After challenging the memory T cells with a booster vaccination of HBs Ag or Tet-Tox (Fig. 5C ), a time-dependent increase of Agreactive (CD154 + ) T cells was observed for CD4 + Teff. The frequency of circulating Ag-reactive CD154 + Tregs did not significantly change, leading to a temporarily increase of the CD154 + CD4
+ Teff/CD154 + Treg ratio with a maximum at 2 wk (Fig. 5D ).
Discussion
In this study we show the presence of human Ag-reactive nTregs in the peripheral blood. Reactivity for CMV Ag was initially studied, as the frequency of CMV Ag-reactive T cells is remarkably high, thereby facilitating the identification and isolation of Ag-reactive Tregs. Activated CD4 + Teff or iTregs with (temporarily) increased FOXP3 expression and increased CD25 and decreased CD127 expression may mimick nTregs (8, 20) . However, there are a number of arguments in favor of the conclusion that Ag-reactive CD154 + cells within the sorted CD25 ++ CD127 2 CD4 + T cell population are true nTregs.
First, the expression in time of CD154 on Tregs was different from CD4 + Teff, as the rapid biphasic expression pattern (14) was not observed. Instead, similar to Ag-specific induction of CD137 on the cell surface, the expression was detectable after 6 h and reached the maximal level after 24 h stimulation. This implies that after 6 h Agspecific stimulation all CD154 + T cells are found within the CD4 + Teff, which potentially offers the possibility to discriminate Ag- Second, the CD154 + Tregs were found in a homogeneous population of Tregs characterized by the simultaneous expression of CD127 at low levels, as well as CD25 and FOXP3 at high levels. Additionally, the FOXP3 expression in CD154 + Tregs was still significantly higher at 24 h compared with the unchanged FOXP3 expression in CD154 + CD4 + Teff. Third, the unchanged highly demethylated TSDR FOXP3 within CD154 + Tregs was in favor of the development of CMV Agreactive Tregs from natural occurring Tregs instead of a development from CD4 + Teff.
Fourth, the Treg population we isolated expressed low levels of inflammatory cytokines after polyclonal activation with PMA/ionomycin, as has been reported before (8, 9) .
The final and most compelling argument is the observation that freshly isolated Ag-reactive CD154 + Tregs showed Ag-reactive T cell suppression and could be efficiently expanded in vitro by Ag-specific stimulation combined with exogenous IL-2 and IL-15. These Ag-expanded CD154 + Tregs were highly suppressive in an Ag-specific fashion while still displaying a nonspecific, but much less effective suppression when tested in an assay of polyclonalstimulated T cells or other recall Ags.
Based on these findings we conclude that Ag-reactive CD154 + Teff, in presence of a 1:5 ratio of the different Tregs, to CMV Ag and PHA Ag, respectively. Additionally, the different Treg fractions were also expanded using CMV Ag or CD3/CD28 beads (polyclonal). The fold increase of Ag-specific and polyclonal expansion of the different Treg fractions is depicted in G. As a negative control, the Ag-specific expansion protocol was applied to Tregs of a CMV-seronegative individual. A typical example of the FOXP3 expression at day 9 CMV Ag-expanded CD154-expressing Tregs is given in H (the open histogram resembles the isotype control staining, whereas the closed one resembles the FOXP3 staining). CMV Ag-expanded CD154-enriched Tregs were also tested for their suppressive capacity. The suppressive capacity of the different Treg fractions was tested using a proliferation assay with [ + Teff. Our data obtained in human individuals are in accordance with the data from in vivo tracking of color-coded Teff and Treg in the allograft response against pancreatic islets transplants in the mouse (22) . Using this elegant technique, it was shown that natural Tregs and Teff accumulate at the same pace within the transplant. This result is very similar to the observations made on the local T cell immune response after cutaneous inoculation with tuberculin-purified protein derivative in humans (11) . However, similar to our vaccination data, numbers of Tregs within the peripheral blood hardly change after islet transplantation and do not show the steep increase as observed for Teff (22) . Therefore, after vaccination it may be a possibility that Ag-reactive Tregs, having a memory lymphoid homing profile (CD45RO ++ Tregs share equally complex and comparable repertoires with CD4 + CD25 2 counterparts (24). In the latter study it was also a remarkable finding that CMV seropositivity gave rise to a similar shift in Vb repertoire in Teff and Tregs. The possibility of direct recognition of Ag-reactive Tregs will facilitate further research in this direction, aiming a more complete understanding of the significance and interaction of Tregs in humane disease and immune responses. Additionally, isolation and propagation of Ag-reactive T cells identified on the single cell level is of potential benefit for future immunotherapy with Tregs.
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